# Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT04004871** · PHASE2 · COMPLETED · sponsor: **Guangxi Medical University** · enrollment: 60 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Nasopharynx Cancer

## Interventions

- **DRUG:** Nab-paclitaxel, Cisplatin and Fluorouracil
- **RADIATION:** concurrent chemoradiotherapy

## Key facts

- **NCT ID:** NCT04004871
- **Lead sponsor:** Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2022-03-29
- **Final completion:** 2025-10-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04004871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04004871, "Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04004871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*